Stefano G Daniele, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-23 | 1 | 2024 | 198 | 0.850 |
Why?
|
| Acne Vulgaris | 1 | 2022 | 355 | 0.580 |
Why?
|
| Cicatrix | 1 | 2022 | 782 | 0.560 |
Why?
|
| Psoriasis | 1 | 2024 | 933 | 0.530 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2015 | 49 | 0.500 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 710 | 0.500 |
Why?
|
| Biological Products | 1 | 2024 | 914 | 0.500 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 2725 | 0.450 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 348 | 0.430 |
Why?
|
| Cytological Techniques | 1 | 2014 | 218 | 0.400 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2017 | 581 | 0.390 |
Why?
|
| Protein Folding | 1 | 2015 | 867 | 0.380 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1849 | 0.340 |
Why?
|
| Microglia | 2 | 2017 | 1347 | 0.320 |
Why?
|
| Immunophenotyping | 1 | 2014 | 1870 | 0.320 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 744 | 0.320 |
Why?
|
| Brain Ischemia | 2 | 2021 | 3128 | 0.310 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2024 | 346 | 0.310 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 5796 | 0.210 |
Why?
|
| Sebaceous Glands | 1 | 2022 | 42 | 0.210 |
Why?
|
| Warm Ischemia | 1 | 2022 | 58 | 0.200 |
Why?
|
| Lipogenesis | 1 | 2024 | 209 | 0.200 |
Why?
|
| Cytoprotection | 1 | 2022 | 200 | 0.200 |
Why?
|
| Swine | 2 | 2022 | 5903 | 0.180 |
Why?
|
| Dermatologic Agents | 1 | 2024 | 306 | 0.180 |
Why?
|
| Perfusion | 2 | 2022 | 1376 | 0.180 |
Why?
|
| Adipose Tissue, White | 2 | 2024 | 365 | 0.170 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5754 | 0.150 |
Why?
|
| Brain | 2 | 2021 | 26863 | 0.140 |
Why?
|
| Aminopeptidases | 1 | 2016 | 95 | 0.130 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 352 | 0.130 |
Why?
|
| Autopsy | 1 | 2019 | 1006 | 0.120 |
Why?
|
| Proteostasis Deficiencies | 1 | 2015 | 39 | 0.120 |
Why?
|
| Cell Survival | 2 | 2022 | 5796 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 392 | 0.120 |
Why?
|
| Microcirculation | 1 | 2019 | 1277 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2017 | 23362 | 0.110 |
Why?
|
| Lewy Body Disease | 1 | 2015 | 248 | 0.100 |
Why?
|
| Cadherins | 1 | 2017 | 898 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2017 | 2675 | 0.100 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 755 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2016 | 705 | 0.100 |
Why?
|
| Skin | 1 | 2022 | 4467 | 0.080 |
Why?
|
| Animals | 9 | 2024 | 167838 | 0.070 |
Why?
|
| Breast | 1 | 2016 | 1979 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4262 | 0.060 |
Why?
|
| Mice | 6 | 2024 | 81138 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2022 | 1953 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 21981 | 0.050 |
Why?
|
| Oligopeptides | 2 | 2017 | 1187 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2015 | 2843 | 0.050 |
Why?
|
| Humans | 6 | 2024 | 759255 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 11908 | 0.040 |
Why?
|
| Hypoxia, Brain | 1 | 2019 | 138 | 0.040 |
Why?
|
| Cell Death | 1 | 2022 | 1669 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2019 | 730 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2018 | 752 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 2019 | 490 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 64879 | 0.030 |
Why?
|
| Vasodilation | 1 | 2019 | 964 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 1174 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2022 | 9374 | 0.030 |
Why?
|
| Ischemia | 1 | 2022 | 1893 | 0.030 |
Why?
|
| Neuroglia | 1 | 2019 | 944 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 1024 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 1066 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1134 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1840 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 686 | 0.020 |
Why?
|
| Protein Transport | 1 | 2017 | 1966 | 0.020 |
Why?
|
| Adipocytes | 1 | 2018 | 1179 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3804 | 0.020 |
Why?
|
| Synapses | 1 | 2019 | 1748 | 0.020 |
Why?
|
| Body Composition | 1 | 2018 | 2414 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1914 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2486 | 0.020 |
Why?
|
| Liver | 1 | 2024 | 7514 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2824 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10827 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2024 | 12106 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 3193 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14381 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18968 | 0.010 |
Why?
|
| Rats | 1 | 2017 | 23694 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11476 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8491 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16532 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18110 | 0.010 |
Why?
|
| Neurons | 1 | 2019 | 9411 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10747 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40109 | 0.010 |
Why?
|
| Obesity | 1 | 2018 | 12896 | 0.010 |
Why?
|
| Male | 1 | 2018 | 358719 | 0.000 |
Why?
|
| Female | 1 | 2018 | 390240 | 0.000 |
Why?
|